{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:43:19Z","timestamp":1792809799156,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"University of Padova","doi-asserted-by":"crossref","award":["TREV_BIRD2223_01"],"award-info":[{"award-number":["TREV_BIRD2223_01"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P20222YKP8"],"award-info":[{"award-number":["P20222YKP8"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20223RYYFC"],"award-info":[{"award-number":["20223RYYFC"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["25899"],"award-info":[{"award-number":["25899"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NextGenerationEU-MUR PNRR","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}]},{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI164033"],"award-info":[{"award-number":["R21AI164033"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-06015-x","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T03:35:25Z","timestamp":1768102525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Letermovir shows antiviral and neuroprotective effects in differentiating neurons and cerebral organoids mimicking human developing brain"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-8045","authenticated-orcid":false,"given":"Beatrice","family":"Mercorelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pianezzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Faggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravit","family":"Arav-Boger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-861X","authenticated-orcid":false,"given":"Arianna","family":"Loregian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-7240","authenticated-orcid":false,"given":"Marta","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"6015_CR1","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","volume":"17","author":"WD Rawlinson","year":"2017","unstructured":"Rawlinson WD, Boppana SB, Fowler KB et al (2017) Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 17:e177\u2013e188. https:\/\/doi.org\/10.1016\/S1473-3099(17)30143-3","journal-title":"Lancet Infect Dis"},{"key":"6015_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/dmcn.14682","volume":"63","author":"E Gordon-Lipkin","year":"2021","unstructured":"Gordon-Lipkin E, Hoon A, Pardo CA (2021) Prenatal cytomegalovirus, rubella, and Zika virus infections associated with developmental disabilities: past, present, and future. Dev Med Child Neurol 63:135\u2013143. https:\/\/doi.org\/10.1111\/dmcn.14682","journal-title":"Dev Med Child Neurol"},{"key":"6015_CR3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3648","volume":"140","author":"SB Boppana","year":"2017","unstructured":"Boppana SB, Fowler KB (2017) Insight into long-term neurodevelopmental outcomes in asymptomatic congenital CMV infection. Pediatrics 140:e20172526. https:\/\/doi.org\/10.1542\/peds.2017-3648","journal-title":"Pediatrics"},{"key":"6015_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamapediatrics.2020.3009","volume":"174","author":"CJ Messinger","year":"2020","unstructured":"Messinger CJ, Lipsitch M, Bateman BT et al (2020) Association between congenital cytomegalovirus and the prevalence at birth of microcephaly in the united States. JAMA Pediatr 174:1159\u20131167. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.3009","journal-title":"JAMA Pediatr"},{"key":"6015_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","volume":"223","author":"M Leruez-Ville","year":"2020","unstructured":"Leruez-Ville M, Foulon I, Pass R et al (2020) Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol 223:330\u2013349. https:\/\/doi.org\/10.1016\/j.ajog.2020.02.018","journal-title":"Am J Obstet Gynecol"},{"key":"6015_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/archdischild-2018-316010","volume":"104","author":"J Retzler","year":"2019","unstructured":"Retzler J, Hex N, Bartlett C et al (2019) Economic cost of congenital CMV in the UK. Arch Dis Child 104:559\u2013563. https:\/\/doi.org\/10.1136\/archdischild-2018-316010","journal-title":"Arch Dis Child"},{"key":"6015_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijns9020030","volume":"9","author":"MP Zappas","year":"2023","unstructured":"Zappas MP, Devereaux A, Pesch MH (2023) The psychosocial impact of congenital cytomegalovirus on caregivers and families: lived experiences and review of the literature. Int J Neonatal Screen 9:30. https:\/\/doi.org\/10.3390\/ijns9020030","journal-title":"Int J Neonatal Screen"},{"key":"6015_CR8","doi-asserted-by":"publisher","first-page":"1321116","DOI":"10.3389\/fmicb.2023.1321116","volume":"14","author":"C Gourin","year":"2023","unstructured":"Gourin C, Alain S, Hantz S (2023) Anti-CMV therapy, what next? A systematic review. Front Microbiol 14:1321116. https:\/\/doi.org\/10.3389\/fmicb.2023.1321116","journal-title":"Front Microbiol"},{"key":"6015_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.antiviral.2018.09.003","volume":"159","author":"WJ Britt","year":"2018","unstructured":"Britt WJ, Prichard MN (2018) New therapies for human cytomegalovirus infections. Antivir Res 159:153\u2013174. https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.003","journal-title":"Antivir Res"},{"key":"6015_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/rmv.558","volume":"18","author":"B Mercorelli","year":"2009","unstructured":"Mercorelli B, Sinigalia E, Loregian A et al (2009) Human cytomegalovirus DNA replication: antiviral targets and drugs. Rev Med Virol 18:177\u2013210. https:\/\/doi.org\/10.1002\/rmv.558","journal-title":"Rev Med Virol"},{"key":"6015_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pharmthera.2011.04.007","volume":"131","author":"B Mercorelli","year":"2011","unstructured":"Mercorelli B, Lembo D, Pal\u00f9 G, Loregian A (2011) Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives. Pharmacol Ther 131:309\u2013329. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.04.007","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6015_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.antiviral.2006.03.013","volume":"72","author":"L Naesens","year":"2006","unstructured":"Naesens L, Stephens CE, Andrei G et al (2006) Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses. Antivir Res 72(1):60\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2006.03.013","journal-title":"Antivir Res"},{"key":"6015_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1128\/aac.00988-08","volume":"53","author":"B Mercorelli","year":"2009","unstructured":"Mercorelli B, Muratore G, Sinigalia E et al (2009) A 6-aminoquinolone compound, WC5, with potent and selective anti-human cytomegalovirus activity. Antimicrob Agents Chemother 53:312\u2013315. https:\/\/doi.org\/10.1128\/aac.00988-08","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR14","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1128\/AAC.01730-09","volume":"54","author":"A Loregian","year":"2010","unstructured":"Loregian A, Mercorelli B, Muratore G et al (2010) The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein. Antimicrob Agents Chemother 54:1930\u20131940. https:\/\/doi.org\/10.1128\/AAC.01730-09","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR15","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1128\/AAC.00721-10","volume":"54","author":"B Mercorelli","year":"2010","unstructured":"Mercorelli B, Oreste P, Sinigalia E et al (2010) Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus. Antimicrob Agents Chemother 54:4561\u20134567. https:\/\/doi.org\/10.1128\/AAC.00721-10","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.antiviral.2017.12.014","volume":"150","author":"B Mercorelli","year":"2018","unstructured":"Mercorelli B, Luganini A, Celegato M, Pal\u00f9 G, Gribaudo G, Loregian A (2018) Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein. Antivir Res 150:130\u2013136. https:\/\/doi.org\/10.1016\/j.antiviral.2017.12.014","journal-title":"Antivir Res"},{"key":"6015_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.antiviral.2019.02.006","volume":"164","author":"A Luganini","year":"2019","unstructured":"Luganini A, Mercorelli B, Messa L, Pal\u00f9 G, Gribaudo G, Loregian A (2019) The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral immediate early-2 (IE2) protein transactivating activity. Antivir Res 164:52\u201360. https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.006","journal-title":"Antivir Res"},{"key":"6015_CR18","doi-asserted-by":"publisher","first-page":"e00056","DOI":"10.1128\/AAC.00056-20","volume":"64","author":"B Mercorelli","year":"2020","unstructured":"Mercorelli B, Luganini A, Celegato M, Pal\u00f9 G, Gribaudo G, Lepesheva GI, Loregian A (2020) The clinically approved antifungal drug posaconazole inhibits human cytomegalovirus replication. Antimicrob Agents Chemother 64:e00056\u2013e00020. https:\/\/doi.org\/10.1128\/AAC.00056-20","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.chembiol.2015.12.012","volume":"23","author":"B Mercorelli","year":"2016","unstructured":"Mercorelli B, Luganini A, Nannetti G, Tabarrini O, Pal\u00f9 G, Gribaudo G, Loregian A (2016) Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication. Cell Chem Biol 23:340\u201351. https:\/\/doi.org\/10.1016\/j.chembiol.2015.12.012","journal-title":"Cell Chem Biol"},{"key":"6015_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01735-18","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang Y, Mukhopadhyay R, Roy S et al (2019) Inhibition of cytomegalovirus replication with extended-half-life synthetic ozonides. Antimicrob Agents Chemother 29:e01735-18. https:\/\/doi.org\/10.1128\/AAC.01735-18","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105083","volume":"191","author":"SA Ross","year":"2020","unstructured":"Ross SA, Kimberlin D (2020) Clinical outcome and the role of antivirals in congenital cytomegalovirus infection. Antiviral Res 191:105083. https:\/\/doi.org\/10.1016\/j.antiviral.2021.105083","journal-title":"Antiviral Res"},{"key":"6015_CR22","doi-asserted-by":"publisher","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","volume":"215","author":"M Leruez-Ville","year":"2016","unstructured":"Leruez-Ville M, Ghout I, Bussi\u00e8res L et al (2016) In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol 215:462.e1-462.e10. https:\/\/doi.org\/10.1016\/j.ajog.2016.04.003","journal-title":"Am J Obstet Gynecol"},{"key":"6015_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","volume":"396","author":"K Shahar-Nissan","year":"2020","unstructured":"Shahar-Nissan K, Pardo J, Peled O et al (2020) Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet 396:779\u2013785. https:\/\/doi.org\/10.1016\/S0140-6736(20)31868-7","journal-title":"Lancet"},{"key":"6015_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/uog.26039","volume":"61","author":"C Egloff","year":"2023","unstructured":"Egloff C, Sibiude J, Vauloup-Fellous C et al (2023) New data on efficacy of valacyclovir in secondary prevention of maternal\u2013fetal transmission of cytomegalovirus. Ultrasound Obstet Gynecol 61:59\u201366. https:\/\/doi.org\/10.1002\/uog.26039","journal-title":"Ultrasound Obstet Gynecol"},{"key":"6015_CR25","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1093\/jac\/dkae247","volume":"79","author":"N Bourgon","year":"2024","unstructured":"Bourgon N, Lopez R, Fourgeaud J et al (2024) In utero treatment of congenital cytomegalovirus infection with valganciclovir: an observational study on safety and effectiveness. J Antimicrob Chemother 79:2500\u20132508. https:\/\/doi.org\/10.1093\/jac\/dkae247","journal-title":"J Antimicrob Chemother"},{"key":"6015_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00023-08","volume":"22","author":"MC Cheeran","year":"2009","unstructured":"Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22:99\u2013126. https:\/\/doi.org\/10.1128\/CMR.00023-08","journal-title":"Clin Microbiol Rev"},{"key":"6015_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41577-020-00474-y","volume":"21","author":"O Harschnitz","year":"2021","unstructured":"Harschnitz O, Studer L (2021) Human stem cell models to study host-virus interactions in the central nervous system. Nat Rev Immunol 21:441\u2013453. https:\/\/doi.org\/10.1038\/s41577-020-00474-y","journal-title":"Nat Rev Immunol"},{"key":"6015_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-022-00723-9","volume":"18","author":"OL Eichm\u00fcller","year":"2022","unstructured":"Eichm\u00fcller OL, Knoblich JA (2022) Human cerebral organoids - a new tool for clinical neurology research. Nat Rev Neurol 18:661\u2013680. https:\/\/doi.org\/10.1038\/s41582-022-00723-9","journal-title":"Nat Rev Neurol"},{"key":"6015_CR29","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/JVI.02161-09","volume":"84","author":"MH Luo","year":"2010","unstructured":"Luo MH, Hannemann H, Kulkarni AS et al (2010) Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J Virol 84:3528\u20133541. https:\/\/doi.org\/10.1128\/JVI.02161-09","journal-title":"J Virol"},{"key":"6015_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.antiviral.2016.02.007","volume":"29","author":"TM Bigley","year":"2016","unstructured":"Bigley TM, McGivern JV, Ebert AD et al (2016) Impact of a cytomegalovirus kinase inhibitor on infection and neuronal progenitor cell differentiation. Antiviral Res 29:67\u201373. https:\/\/doi.org\/10.1016\/j.antiviral.2016.02.007","journal-title":"Antiviral Res"},{"key":"6015_CR31","doi-asserted-by":"publisher","first-page":"e49700","DOI":"10.1371\/journal.pone.0049700","volume":"7","author":"L D\u2019Aiuto","year":"2012","unstructured":"D\u2019Aiuto L, Di Maio R, Heath B et al (2012) Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS ONE 7:e49700. https:\/\/doi.org\/10.1371\/journal.pone.0049700","journal-title":"PLoS ONE"},{"key":"6015_CR32","doi-asserted-by":"publisher","first-page":"e0225123","DOI":"10.1128\/mbio.02251-23","volume":"14","author":"JW Adelman","year":"2023","unstructured":"Adelman JW, Rosas-Rogers S, Schumacher ML et al (2023) Human cytomegalovirus induces significant structural and functional changes in terminally differentiated human cortical neurons. mBio 14:e0225123. https:\/\/doi.org\/10.1128\/mbio.02251-23","journal-title":"mBio"},{"key":"6015_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105816","volume":"223","author":"M Trevisan","year":"2024","unstructured":"Trevisan M, Pianezzola A, Onorati M et al (2024) Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors. Antiviral Res 223:105816. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105816","journal-title":"Antiviral Res"},{"key":"6015_CR34","doi-asserted-by":"publisher","unstructured":"Gabrielli L, Bonasoni MP, Lazzarotto T et al (2009) Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46: S16-21. oi: https:\/\/doi.org\/10.1016\/j.jcv.2009.09.026","DOI":"10.1016\/j.jcv.2009.09.026"},{"key":"6015_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/NEN.0000000000000038","volume":"73","author":"N Teissier","year":"2014","unstructured":"Teissier N, Fallet-Bianco C, Delezoide AL et al (2014) Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol 73:143\u201358. https:\/\/doi.org\/10.1097\/NEN.0000000000000038","journal-title":"J Neuropathol Exp Neurol"},{"key":"6015_CR36","doi-asserted-by":"publisher","first-page":"e1005547","DOI":"10.1371\/journal.ppat.1005547","volume":"12","author":"M Rolland","year":"2016","unstructured":"Rolland M, Li X, Sellier Y et al (2016) PPAR\u03b3 is activated during congenital cytomegalovirus infection and inhibits neuronogenesis from human neural stem cells. PLoS Pathog 12:e1005547. https:\/\/doi.org\/10.1371\/journal.ppat.1005547","journal-title":"PLoS Pathog"},{"key":"6015_CR37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s10571-022-01258-9","volume":"43","author":"G Piccirilli","year":"2023","unstructured":"Piccirilli G, Gabrielli L, Bonasoni MP et al (2023) Fetal brain damage in human fetuses with congenital cytomegalovirus infection: histological features and viral tropism. Cell Mol Neurobiol 43:1385\u20131399. https:\/\/doi.org\/10.1007\/s10571-022-01258-9","journal-title":"Cell Mol Neurobiol"},{"key":"6015_CR38","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/erm.2024.35","volume":"27","author":"G Crawford","year":"2024","unstructured":"Crawford G, Soper O, Kang E et al (2024) Advancing insights into virus-induced neurodevelopmental disorders through human brain organoid modelling. Expert Rev Mol Med 27:e1. https:\/\/doi.org\/10.1017\/erm.2024.35","journal-title":"Expert Rev Mol Med"},{"key":"6015_CR39","doi-asserted-by":"publisher","first-page":"1129451","DOI":"10.3389\/fcimb.2023.1129451","volume":"13","author":"SK Halonen","year":"2023","unstructured":"Halonen SK (2023) Use of in vitro derived human neuronal models to study host-parasite interactions of Toxoplasma gondii in neurons and neuropathogenesis of chronic toxoplasmosis. Front Cell Infect Microbiol 13:1129451. https:\/\/doi.org\/10.3389\/fcimb.2023.1129451","journal-title":"Front Cell Infect Microbiol"},{"key":"6015_CR40","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/JVI.00954-19","volume":"93","author":"SL Sison","year":"2019","unstructured":"Sison SL, O\u2019Brien BS, Johnson AJ et al (2019) Human cytomegalovirus disruption of calcium signaling in neural progenitor cells and organoids. J Virol 93:e00954\u2013e00919. https:\/\/doi.org\/10.1128\/JVI.00954-19","journal-title":"J Virol"},{"key":"6015_CR41","doi-asserted-by":"publisher","first-page":"e00957","DOI":"10.1128\/JVI.00957-19","volume":"93","author":"RM Brown","year":"2019","unstructured":"Brown RM, Rana PSJB, Jaeger HK et al (2019) Human cytomegalovirus compromises development of cerebral organoids. J Virol 93:e00957\u2013e00919. https:\/\/doi.org\/10.1128\/JVI.00957-19","journal-title":"J Virol"},{"key":"6015_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100002","volume":"1","author":"G Sun","year":"2020","unstructured":"Sun G, Chiuppesi F, Chen X et al (2020) Modeling human cytomegalovirus-induced microcephaly in human iPSC-derived brain organoids. Cell Rep Med 1:100002. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100002","journal-title":"Cell Rep Med"},{"key":"6015_CR43","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.stem.2021.03.004","volume":"28","author":"V Krenn","year":"2021","unstructured":"Krenn V, Bosone C, Burkard TR et al (2021) Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly. Cell Stem Cell 28:1362\u20131379e7. https:\/\/doi.org\/10.1016\/j.stem.2021.03.004","journal-title":"Cell Stem Cell"},{"key":"6015_CR44","doi-asserted-by":"publisher","first-page":"104098","DOI":"10.1016\/j.isci.2022.104098","volume":"25","author":"BS O\u2019Brien","year":"2022","unstructured":"O\u2019Brien BS, Mokry RL, Schumacher ML et al (2022) Downregulation of neurodevelopmental gene expression in iPSC-derived cerebral organoids upon infection by human cytomegalovirus. iScience 25:104098. https:\/\/doi.org\/10.1016\/j.isci.2022.104098","journal-title":"iScience"},{"key":"6015_CR45","doi-asserted-by":"publisher","first-page":"e0012622","DOI":"10.1128\/jvi.00126-22","volume":"96","author":"RL Mokry","year":"2022","unstructured":"Mokry RL, O\u2019Brien BS, Adelman JW et al (2022) Nitric oxide attenuates human cytomegalovirus infection yet disrupts neural cell differentiation and tissue organization. J Virol 96:e0012622. https:\/\/doi.org\/10.1128\/jvi.00126-22","journal-title":"J Virol"},{"key":"6015_CR46","doi-asserted-by":"publisher","first-page":"e0171822","DOI":"10.1128\/jvi.01718-22","volume":"97","author":"EC Ijezie","year":"2023","unstructured":"Ijezie EC, O\u2019Dowd JM, Kuan MI et al (2023) HCMV infection reduces Nidogen-1 Expression, contributing to impaired neural rosette development in brain organoids. J Virol 97:e0171822. https:\/\/doi.org\/10.1128\/jvi.01718-22","journal-title":"J Virol"},{"key":"6015_CR47","doi-asserted-by":"publisher","first-page":"e0069623","DOI":"10.1128\/jvi.00696-23","volume":"97","author":"BS O\u2019Brien","year":"2023","unstructured":"O\u2019Brien BS, Mokry RL, Schumacher ML et al (2023) Neutralizing antibodies with neurotropic factor treatment maintain neurodevelopmental gene expression upon exposure to human cytomegalovirus. J Virol 97:e0069623. https:\/\/doi.org\/10.1128\/jvi.00696-23","journal-title":"J Virol"},{"key":"6015_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.molcel.2018.03.012","volume":"70","author":"A Ordureau","year":"2018","unstructured":"Ordureau A, Paulo JA, Zhang W et al (2018) Dynamics of PARKIN-dependent mitochondrial ubiquitylation in induced neurons and model systems revealed by digital snapshot proteomics. Mol Cell 70:211-227.e8. https:\/\/doi.org\/10.1016\/j.molcel.2018.03.012","journal-title":"Mol Cell"},{"key":"6015_CR49","doi-asserted-by":"publisher","first-page":"e9174","DOI":"10.1371\/journal.pone.0009174","volume":"5","author":"S Straschewski","year":"2010","unstructured":"Straschewski S, Warmer M, Frascaroli G et al (2010) Human cytomegaloviruses expressing yellow fluorescent fusion proteins\u2013characterization and use in antiviral screening. PLoS One 5:e9174. https:\/\/doi.org\/10.1371\/journal.pone.0009174","journal-title":"PLoS One"},{"key":"6015_CR50","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1099\/0022-1317-82-6-1429","volume":"82","author":"MG Revello","year":"2001","unstructured":"Revello MG, Baldanti F, Percivalle E et al (2001) In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J Gen Virol 82:1429\u20131438. https:\/\/doi.org\/10.1099\/0022-1317-82-6-1429","journal-title":"J Gen Virol"},{"key":"6015_CR51","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.1128\/JVI.00663-","volume":"83","author":"BL Strang","year":"2009","unstructured":"Strang BL, Sinigalia E, Silva LA, Coen DM, Loregian A (2009) Analysis of the association of the human cytomegalovirus 1 DNA polymerase subunit UL44 with the viral DNA replication factor UL84. J Virol 83:7581\u20137589. https:\/\/doi.org\/10.1128\/JVI.00663-","journal-title":"J Virol"},{"key":"6015_CR52","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9:2329\u20132340. https:\/\/doi.org\/10.1038\/nprot.2014.158","journal-title":"Nat Protoc"},{"key":"6015_CR53","doi-asserted-by":"publisher","first-page":"e49630","DOI":"10.1371\/journal.pone.0049630","volume":"7","author":"E Sinigalia","year":"2012","unstructured":"Sinigalia E, Alvisi G, Segr\u00e9 CV et al (2012) The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner. PLoS One 7:e49630. https:\/\/doi.org\/10.1371\/journal.pone.0049630","journal-title":"PLoS One"},{"key":"6015_CR54","doi-asserted-by":"publisher","first-page":"e0309722","DOI":"10.1128\/mbio.03097-22","volume":"14","author":"M Celegato","year":"2023","unstructured":"Celegato M, Sturlese M, Vasconcelos Costa V et al (2023) Small-molecule inhibitor of flaviviral NS3-NS5 interaction with broad-spectrum activity and efficacy in vivo. mBio 14:e0309722. https:\/\/doi.org\/10.1128\/mbio.03097-22","journal-title":"mBio"},{"key":"6015_CR55","doi-asserted-by":"publisher","first-page":"e01627","DOI":"10.1128\/AAC.01627-20","volume":"65","author":"ST Hamilton","year":"2020","unstructured":"Hamilton ST, Marschall M, Rawlinson WD (2020) Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy. Antimicrob Agents Chemother 65:e01627\u2013e01620. https:\/\/doi.org\/10.1128\/AAC.01627-20","journal-title":"Antimicrob Agents Chemother"},{"key":"6015_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/path.5640","volume":"254","author":"M Rolland","year":"2021","unstructured":"Rolland M, Martin H, Bergamelli M et al (2021) Human cytomegalovirus infection is associated with increased expression of the lissencephaly gene PAFAH1B1 encoding LIS1 in neural stem cells and congenitally infected brains. J Pathol 254:92\u2013102. https:\/\/doi.org\/10.1002\/path.5640","journal-title":"J Pathol"},{"key":"6015_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ydbio.2016.06.037","volume":"420","author":"I Kelava","year":"2016","unstructured":"Kelava I, Lancaster MA (2016) Dishing out mini-brains: current progress and future prospects in brain organoid research. Dev Biol 420:199\u2013209. https:\/\/doi.org\/10.1016\/j.ydbio.2016.06.037","journal-title":"Dev Biol"},{"key":"6015_CR58","doi-asserted-by":"publisher","unstructured":"Roy S, Kapoor A, Zhu F et al (2020) Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA120.014116","DOI":"10.1074\/jbc.RA120.014116"},{"key":"6015_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcdb.2020.05.023","volume":"111","author":"Y Xiang","year":"2021","unstructured":"Xiang Y, Cakir B, Park I-H (2021) Deconstructing and reconstructing the human brain with regionally specified brain organoids. Semin Cell Dev Biol 111:40\u201351. https:\/\/doi.org\/10.1016\/j.semcdb.2020.05.023","journal-title":"Semin Cell Dev Biol"},{"key":"6015_CR60","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","volume":"223","author":"C Chatzakis","year":"2020","unstructured":"Chatzakis C, Ville Y, Makrydimas G et al (2020) Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol 223:870\u2013883. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.038","journal-title":"Am J Obstet Gynecol"},{"key":"6015_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106233","volume":"241","author":"LA Mulder","year":"2025","unstructured":"Mulder LA, da Vieira S\u00e1 R, Korsten J et al (2025) Effect of antivirals on clinical and lab-adapted human cytomegalovirus strains using induced pluripotent stem cell-derived human neural models. Antiviral Res 241:106233. https:\/\/doi.org\/10.1016\/j.antiviral.2025.106233","journal-title":"Antiviral Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-06015-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:01:57Z","timestamp":1773248517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-06015-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6015"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-06015-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"139"}}